Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

Immune evasion

The Omicron subvariants BA.1, BA.4, BA.5 as well as Q.1.1 have a high number of mutations in the spike protein. Some of these mutations are escape mutations that allow the virus to escape neutralization by antibodies. In addition, resistance to biotechnologically produced antibodies, which are administered to high-risk patients as a preventive measure or as therapy for a diagnosed SARS-CoV-2 infection, is also developing. Omicron sub-lineage BQ.1.1 is the first variant resistant to all antibody therapies currently approved by the EMA (European Medicines Agency) and/or FDA (US Food and Drug Administration).

New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies

Substack subscription form sign up

Comments

  • Josh Mitteldorf on Red States and Blue States Are Becoming the Same Unhappy Country
  • Josh Mitteldorf on Scientists Have Written the Rules for First Contact, and Step One Is Don’t Panic
  • John E on A New Theory Says DMT Entities Might Be Real, and Proposes How to Test It
  • ScienceBlog.com on A New Theory Says DMT Entities Might Be Real, and Proposes How to Test It
  • John E on A New Theory Says DMT Entities Might Be Real, and Proposes How to Test It
© 2026 ScienceBlog.com | Follow our RSS / XML feed